Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | CDC25B | P30305 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TPMT | P51580 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3841219 | 1.00 | LCK (0.56) | LCKFYNCDC25BCA12CA1 | |
| SCHEMBL1602834 | 0.98 | LCK (0.54) | LCKFYNCDC25BCA12CA1 | |
| SCHEMBL25201100 | 0.87 | TTR (0.51) | LCKFYNCDC25BCYP1A2TSHR | |
| SCHEMBL29763597 | 0.85 | CDC25B (0.47) | LCKFYNCDC25BTDP1ALDH1A1 | |
| SCHEMBL976104 | 0.85 | CDC25B (0.47) | LCKFYNCDC25BTDP1ALDH1A1 | |
| SCHEMBL1602218 | 0.83 | CDC25B (0.46) | LCKFYNCDC25BTDP1ALDH1A1 | |
| SCHEMBL7939204 | 0.83 | CDC25B (0.46) | LCKFYNCDC25BTDP1ALDH1A1 | |
| SCHEMBL7941298 | 0.83 | CDC25B (0.46) | LCKFYNCDC25BTDP1ALDH1A1 | |
| SCHEMBL9178407 | 0.83 | CDC25B (0.46) | LCKFYNCDC25BTDP1ALDH1A1 | |
| SCHEMBL29365363 | 0.81 | PTPN1 (0.50) | LCKFYNCDC25BCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12416046-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2025-09-16 | — | — | US | disclosed |
| US-12391834-B2 | Protected dye-labeled reagents | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| US-20250188534-A1 | MODIFIED NUCLEOTIDE REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2025-06-12 | — | — | US | disclosed |
| US-20250002989-A1 | LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2025-01-02 | — | — | US | disclosed |
| EP-3376997-B1 | LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2024-11-13 | — | — | EP | disclosed |
| US-12037641-B2 | Modified nucleotide reagents | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-12000000-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| US-20240158640-A1 | PROTECTED DYE-LABELED REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-20240052410-A1 | MODIFIED NUCLEOTIDE REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-02-15 | — | — | US | disclosed |
| US-11884826-B2 | Protected dye-labeled reagents | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-01-30 | — | — | US | disclosed |
| US-20230366018-A1 | LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| EP-4219506-A1 | PROTECTED DYE-LABELED REAGENTS | Pacific Biosciences Of California, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20220396702-A1 | PROTECTED DYE-LABELED REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2022-12-15 | — | — | US | disclosed |
| US-11466319-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2022-10-11 | — | — | US | disclosed |
| EP-3376996-B1 | PROTECTED DYE-LABELED REAGENTS | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2022-09-07 | — | — | EP | disclosed |
| US-11359235-B2 | Modified nucleotide reagents | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2022-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11359235-B2 | Modified nucleotide reagents | POLL, POLN, POLM | LCK 4784/4885FYN 4853/4885CDC25B 2187/4885 |
| US-20250002989-A1 | LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING | POLL, POLN, POLB | LCK 4785/4885FYN 4840/4885CDC25B 2783/4885 |
| US-12391834-B2 | Protected dye-labeled reagents | POLL, POLB, POLM | LCK 4815/4885FYN 4857/4885CDC25B 2629/4885 |
| US-11884826-B2 | Protected dye-labeled reagents | POLL, POLB, POLM | LCK 4815/4885FYN 4857/4885CDC25B 2629/4885 |
| US-12037641-B2 | Modified nucleotide reagents | POLL, POLN, POLM | LCK 4784/4885FYN 4853/4885CDC25B 2187/4885 |
| US-20220396702-A1 | PROTECTED DYE-LABELED REAGENTS | POLL, POLB, POLM | LCK 4815/4885FYN 4857/4885CDC25B 2629/4885 |
| US-20250188534-A1 | MODIFIED NUCLEOTIDE REAGENTS | POLL, POLN, POLM | LCK 4784/4885FYN 4853/4885CDC25B 2187/4885 |
| US-12416046-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | POLL, POLN, POLB | LCK 4785/4885FYN 4840/4885CDC25B 2783/4885 |
| US-12000000-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | POLL, POLN, POLB | LCK 4785/4885FYN 4840/4885CDC25B 2783/4885 |
| US-20240052410-A1 | MODIFIED NUCLEOTIDE REAGENTS | POLL, POLN, POLM | LCK 4784/4885FYN 4853/4885CDC25B 2187/4885 |
| US-11466319-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | POLL, POLN, POLB | LCK 4785/4885FYN 4840/4885CDC25B 2783/4885 |
| US-20230366018-A1 | LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING | POLL, POLN, POLB | LCK 4785/4885FYN 4840/4885CDC25B 2783/4885 |
| US-20240158640-A1 | PROTECTED DYE-LABELED REAGENTS | POLL, POLB, POLM | LCK 4815/4885FYN 4857/4885CDC25B 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.